Announcements Trials
Browse Landscape

Phase

Phase 2 69Phase 3 45Phase 1/2 35Phase 1 13Phase 2/3 12Phase 4 6Phase NA 4Phase EARLY_PHASE1 2

Status

Completed 32Unknown 12Terminated 5Recruiting 4Withdrawn 3Not yet recruiting 2Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Plasma cell 2Thoracic 1CNS 1

Conditions

Immunoglobulin Light-chain Amyloidosis 2Postoperative Complications 1Lung Neoplasms 1Glioblastoma 1

Interventions

Blood Specimen Collection 104Standard of Care 79Exercise 67Radiotherapy 53Radiosurgery 48Specimen Handling 45Magnetic Resonance Spectroscopy 45Surveys and Questionnaires 44Interviews as Topic 44Practice Guidelines as Topic 43Educational Status 43Methods 41Drug Therapy 35Early Intervention, Educational 30Surgical Procedures, Operative 29Palliative Care 25Control Groups 25Biopsy 24Patient Navigation 18venetoclax 17Cisplatin 17Therapeutics 16Resistance Training 16Proton Therapy 15Magnetic Resonance Imaging 15Behavior Therapy 15Neoadjuvant Therapy 13Cognitive Behavioral Therapy 13Acupuncture Therapy 13Nutritional Status 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase NA × Recruiting × Dexamethasone × Clear all
NCT06192979 2026-03-09

Optimize First-line Treatment for AL Amyloidosis With t (11; 14)

Peking University People's Hospital

Phase NA Recruiting
41 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis

NCT04209218 2025-07-31

Intraoperative Blood Pressure Management and Dexamethasone in Lung Cancer Surgery

Peking University First Hospital

Phase NA Recruiting
1,988 enrolled
Thoracic

Lung Neoplasms, Postoperative Complications

NCT04266977 2025-07-09

RESDEX

Insel Gruppe AG, University Hospital Bern

Phase NA Recruiting
50 enrolled
CNS

Glioblastoma

NCT06455748 2024-06-12

Daratumumab/Daratumumab and Hyaluronidase-fihj in Combination With Pomalidomide and Dexamethasone for the Treatment of Patients With Newly Diagnosed AL Amyloidosis: a Prospective, Multicenter, Single-arm Study

First Affiliated Hospital of Wenzhou Medical University

Phase NA Recruiting
20 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡